Literature DB >> 26486354

The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regions.

Mechelle M Lewis1,2, Guangwei Du1, Eun-Young Lee1, Zeinab Nasralah1, Nicholas W Sterling1, Lijun Zhang1, Daymond Wagner1, Lan Kong3, Alexander I Tröster4, Martin Styner5,6, Paul J Eslinger1, Richard B Mailman1,2, Xuemei Huang1,2.   

Abstract

Cortical and subcortical gray matter (GM) atrophy may progress differently during the course of Parkinson's disease (PD). We delineated and compared the longitudinal pattern of these PD-related changes. Structural MRIs and clinical measures were obtained from 76 PD with different disease durations and 70 Controls at baseline, 18-, and 36 months. Both cortical and subcortical (putamen, caudate, and globus pallidus) GM volumes were obtained, compared, and associated with PD clinical measures at baseline. Their volumes and rates of change also were compared among Controls, PDs, and PD subgroups based on duration of illness [≤1 year (PD(E)), 1-5 years (PD(M)), and >5 years (PD(L))]. Compared to Controls, PD subjects displayed smaller cortical GM and striatal(putamen, caudate, ps ≤0.001), volumes at baseline. Cortical GM volumes were negatively associated with disease duration at baseline, whereas striatal volumes were not. PD subjects demonstrated accelerated volume loss in cortical GM (p = 0.006), putamen (p = 0.034), and caudate (p = 0.008) compared to Controls. Subgroup analyses demonstrated that accelerated cortical atrophy reached statistical significance in PD subjects with duration of illness 1-5 years (PD(M), ps<0.001) and the trend of accelerated atrophy seemed to persist until later stages, whereas striatal atrophy occurred in PD subjects with PD(E) (p = 0.021 for putamen, p = 0.005 for caudate) and PD(M) (p = 0.002 for putamen, p = 0.001 for caudate) that significantly slowed down in PD(L) (ps for PD(L) vs PD(E) or PD(M): <0.01). The pattern of GM loss in PD differs in cortical and subcortical regions, with striatal atrophy occurring earlier and extra-striatal cortical atrophy later.

Entities:  

Mesh:

Year:  2016        PMID: 26486354      PMCID: PMC4838560          DOI: 10.1007/s00415-015-7929-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  35 in total

1.  Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.

Authors:  Richard Camicioli; Jennifer Sabino; Myrlene Gee; Thomas Bouchard; Nancy Fisher; Chris Hanstock; Derek Emery; W R Wayne Martin
Journal:  Mov Disord       Date:  2011-03-25       Impact factor: 10.338

2.  Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.

Authors:  Alexandru Hanganu; Christophe Bedetti; Clotilde Degroot; Béatriz Mejia-Constain; Anne-Louise Lafontaine; Valérie Soland; Sylvain Chouinard; Marie-Andrée Bruneau; Samira Mellah; Sylvie Belleville; Oury Monchi
Journal:  Brain       Date:  2014-03-10       Impact factor: 13.501

3.  Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline.

Authors:  M T Hu; S J White; K R Chaudhuri; R G Morris; G M Bydder; D J Brooks
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

4.  Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis.

Authors:  Chong S Lee; Michael Schulzer; Raúl de la Fuente-Fernández; Edwin Mak; Lisa Kuramoto; Vesna Sossi; Thomas J Ruth; Donald B Calne; A Jon Stoessl
Journal:  Arch Neurol       Date:  2004-12

5.  Grey matter atrophy in cognitively impaired Parkinson's disease.

Authors:  Tracy R Melzer; Richard Watts; Michael R MacAskill; Toni L Pitcher; Leslie Livingston; Ross J Keenan; John C Dalrymple-Alford; Tim J Anderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-09-02       Impact factor: 10.154

6.  A mathematical model of pathogenesis in idiopathic parkinsonism.

Authors:  M Schulzer; C S Lee; E K Mak; F J Vingerhoets; D B Calne
Journal:  Brain       Date:  1994-06       Impact factor: 13.501

7.  Temporal lobe changes in early, untreated Parkinson's disease.

Authors:  W R Wayne Martin; Marguerite Wieler; Myrlene Gee; Richard Camicioli
Journal:  Mov Disord       Date:  2009-10-15       Impact factor: 10.338

8.  Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.

Authors:  C Rossi; D Frosini; D Volterrani; P De Feo; E Unti; V Nicoletti; L Kiferle; U Bonuccelli; R Ceravolo
Journal:  Eur J Neurol       Date:  2009-12-29       Impact factor: 6.089

9.  Progression of cortical thinning in early Parkinson's disease.

Authors:  Naroa Ibarretxe-Bilbao; Carme Junque; Barbara Segura; Hugo C Baggio; Maria J Marti; Francesc Valldeoriola; Nuria Bargallo; Eduardo Tolosa
Journal:  Mov Disord       Date:  2012-11-02       Impact factor: 10.338

10.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

View more
  19 in total

1.  Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson's disease.

Authors:  Jenny Ceccarini; Cindy Casteels; Rawaha Ahmad; Melissa Crabbé; Laura Van de Vliet; Heleen Vanhaute; Mathieu Vandenbulcke; Wim Vandenberghe; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-24       Impact factor: 9.236

2.  Cortical gray and subcortical white matter associations in Parkinson's disease.

Authors:  Nicholas W Sterling; Guangwei Du; Mechelle M Lewis; Steven Swavely; Lan Kong; Martin Styner; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2016-09-28       Impact factor: 4.673

3.  Brain age vector: A measure of brain aging with enhanced neurodegenerative disorder specificity.

Authors:  Chen Ran; Yanwu Yang; Chenfei Ye; Haiyan Lv; Ting Ma
Journal:  Hum Brain Mapp       Date:  2022-09-12       Impact factor: 5.399

4.  Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.

Authors:  Guangwei Du; Mechelle M Lewis; Christopher Sica; Lu He; James R Connor; Lan Kong; Richard B Mailman; Xuemei Huang
Journal:  Mov Disord       Date:  2018-05-14       Impact factor: 10.338

Review 5.  Longitudinal Progression Markers of Parkinson's Disease: Current View on Structural Imaging.

Authors:  Jing Yang; Roxana G Burciu; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-02       Impact factor: 5.081

6.  Clinical Progression of Parkinson's Disease: Insights from the NINDS Common Data Elements.

Authors:  Mechelle M Lewis; Elias Harkins; Eun-Young Lee; Christy Stetter; Bethany Snyder; Tyler Corson; Guangwei Du; Lan Kong; Xuemei Huang
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

7.  Pattern of Reduced Functional Connectivity and Structural Abnormalities in Parkinson's Disease: An Exploratory Study.

Authors:  Rachel Paes Guimarães; Maria Cristina Arci Santos; Alain Dagher; Lidiane Soares Campos; Paula Azevedo; Luiza Gonzaga Piovesana; Brunno Machado De Campos; Kevin Larcher; Yashar Zeighami; Augusto C Scarparo Amato-Filho; Fernando Cendes; Anelyssa Cysne Frota D'Abreu
Journal:  Front Neurol       Date:  2017-01-13       Impact factor: 4.003

8.  Predicting the multi-domain progression of Parkinson's disease: a Bayesian multivariate generalized linear mixed-effect model.

Authors:  Ming Wang; Zheng Li; Eun Young Lee; Mechelle M Lewis; Lijun Zhang; Nicholas W Sterling; Daymond Wagner; Paul Eslinger; Guangwei Du; Xuemei Huang
Journal:  BMC Med Res Methodol       Date:  2017-09-25       Impact factor: 4.615

Review 9.  Structural Imaging and Parkinson's Disease: Moving Toward Quantitative Markers of Disease Progression.

Authors:  N W Sterling; M M Lewis; G Du; X Huang
Journal:  J Parkinsons Dis       Date:  2016-05-27       Impact factor: 5.568

10.  Selection Processing in Noun and Verb Production in Left- and Right-Sided Parkinson's Disease Patients.

Authors:  Sonia Di Tella; Francesca Baglio; Monia Cabinio; Raffaello Nemni; Daniela Traficante; Maria C Silveri
Journal:  Front Psychol       Date:  2018-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.